ReviewMedicines (Basel, Switzerland)2025

Is the Impact of Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors on Bone Metabolism and Fracture Incidence a Class or Drug Effect? A Narrative Review.

George I Lambrou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.